METHENAMINE HIPPURATE Drug Patent Profile
✉ Email this page to a colleague
When do Methenamine Hippurate patents expire, and what generic alternatives are available?
Methenamine Hippurate is a drug marketed by Aurobindo Pharma Ltd, Impax Labs Inc, Ingenus Pharms Llc, Jubilant Cadista, Micro Labs, and Zydus Lifesciences. and is included in six NDAs.
The generic ingredient in METHENAMINE HIPPURATE is methenamine hippurate. There are ten drug master file entries for this compound. Twelve suppliers are listed for this compound. Additional details are available on the methenamine hippurate profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Methenamine Hippurate
A generic version of METHENAMINE HIPPURATE was approved as methenamine hippurate by AUROBINDO PHARMA LTD on July 5th, 2016.
AI Deep Research
Questions you can ask:
- What is the 5 year forecast for METHENAMINE HIPPURATE?
- What are the global sales for METHENAMINE HIPPURATE?
- What is Average Wholesale Price for METHENAMINE HIPPURATE?
Summary for METHENAMINE HIPPURATE
| US Patents: | 0 |
| Applicants: | 6 |
| NDAs: | 6 |
| Finished Product Suppliers / Packagers: | 10 |
| Raw Ingredient (Bulk) Api Vendors: | 1 |
| Clinical Trials: | 9 |
| Patent Applications: | 2,217 |
| Drug Prices: | Drug price information for METHENAMINE HIPPURATE |
| What excipients (inactive ingredients) are in METHENAMINE HIPPURATE? | METHENAMINE HIPPURATE excipients list |
| DailyMed Link: | METHENAMINE HIPPURATE at DailyMed |
Recent Clinical Trials for METHENAMINE HIPPURATE
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| University College, London | PHASE2 |
| University Hospitals of North Midlands NHS Trust | EARLY_PHASE1 |
| Women and Infants Hospital of Rhode Island | PHASE4 |
Medical Subject Heading (MeSH) Categories for METHENAMINE HIPPURATE
Anatomical Therapeutic Chemical (ATC) Classes for METHENAMINE HIPPURATE
US Patents and Regulatory Information for METHENAMINE HIPPURATE
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Aurobindo Pharma Ltd | METHENAMINE HIPPURATE | methenamine hippurate | TABLET;ORAL | 205661-001 | Jul 5, 2016 | AB | RX | No | Yes | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | |||
| Jubilant Cadista | METHENAMINE HIPPURATE | methenamine hippurate | TABLET;ORAL | 217675-001 | Dec 1, 2023 | AB | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | |||
| Impax Labs Inc | METHENAMINE HIPPURATE | methenamine hippurate | TABLET;ORAL | 076411-001 | Jun 20, 2003 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
